4.4 Article

Allosteric modulation of the 5-HT3 receptor

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 11, Issue 1, Pages 75-80

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2011.01.010

Keywords

-

Funding

  1. National Institutes of Health National Institute of Alcoholism and Alcohol Abuse [R21-AA017938]

Ask authors/readers for more resources

5-Hydroxytryptamine type 3 (5-HT3) receptors are ligand-gated ion channels that play important roles in depression, anxiety, substance abuse, emesis, inflammatory pain, spinal nociception, gastrointestinal function, and cardiovascular reflexes. Probably the most studied modulators of 5-HT3 receptors are the high affinity competitive 'setron' antagonists typified by ondansetron. However, there exists a broad range of compounds that modulate the 5-HT3 receptor, not through the orthosteric site but by binding to allosteric sites. Most notable are therapeutic compounds ascribed to certain targets but that allosterically modulate 5-HT3 receptors at clinically relevant concentrations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available